Researchers
- Facilitate clinician scientists’ research around hereditary diseases.
- Automate screening family health history for other common, inherited conditions.
- Population Analytics
- Identify individuals who meet National Comprehensive Cancer Center (NCCN) criteria for hereditary
cancer genetic testing enterprise-wide. Characterize the cohort.
- Identify individuals who meet NCCN criteria for genetic testing that are part of a pre-identified cohort
(i.e., validate that current processes identify all eligible individuals.)
- Facilitate pre-test genetics education and request of genetic testing.
- Facilitate cascade genetic testing.
- Collect targeted family history to determine genetic test eligibility.
- Return negative genetic test results to patients with GARDE-Chat chatbot.
GARDE population health algorithms and GARDE-Chat chatbots have been tested extensively together and pair well. Chatbots created with GARDE-Chat can be used independently to evaluate non-genetics/cancer-related, scalable patient outreach, education, and
healthcare access (e.g. we evaluated the effectiveness of the chatbot to offer COVID-19 test kits in federally qualified
health centers (FQHC)).